Tech Company Financing Transactions
Brickell Biotech Funding Round
Brickell Biotech, based in Boulder, raised $7 million from AMOREPACIFIC Ventures and Palisade Capital Management.
Transaction Overview
Company Name
Announced On
2/27/2013
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series B
Investors
AMOREPACIFIC Ventures (Lead Investor) (Paul Kang)
Proceeds Purpose
The funds from this financing round will be used to support the further development of novel compounds in Brickell's pipeline from pre-clinical proof of concept through clinical testing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5777 Central Ave. 102
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Reginald Hardy
Chief Executive Officer
Robert Brown
Chief Financial Officer
Michael Carruthers
Chief Operating Officer
Andrew Sklawer
Chief Scientific Officer
Patricia Walker
VP - Manufacturing
Herbert Brinkman
VP - Operations
Lawrence Romel
VP - Regulatory Affairs
Deepak Chadha
Browse more venture capital transactions:
Prev: 2/27/2013: Quick Key venture capital transaction
Next: 2/27/2013: Codenvy venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs